SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported) — June 18, 2008
JOHNSON & JOHNSON
(Exact Name of Registrant as Specified in Charter)
| | | | | |
NEW JERSEY
(State or Other Jurisdiction
of Incorporation) | | I-3215
(Commission File Number) | | 22-1024240
(IRS Employer
Identification No.) |
| | | | | |
One Johnson & Johnson Plaza
| | 08933 |
New Brunswick, New Jersey
| | (Zip Code) |
(Address of Principal Executive Offices)
| | |
(732) 524-0400
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| | |
| o | | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| | |
| o | | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| | |
| o | | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| | |
| o | | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
On June 18, 2008, Johnson & Johnson, a New Jersey corporation (the “Company”) commenced and later that day priced an underwritten public offering of $900,000,000 aggregate principal amount of 5.15% Notes due 2018 and $700,000,000 aggregate principal amount of 5.85% Notes due 2038 (collectively, the “Notes”) under the Company’s Registration Statement on Form S-3, Reg. No. 333-149632. The issuance and sale of the Notes are expected to close on June 23, 2008. A legal opinion regarding certain matters of New Jersey and New York law is attached hereto as Exhibit 5.1 and is incorporated herein by reference.
| | |
| Item 9.01 | | Financial Statements and Exhibits. |
(d) Exhibits.
| | | |
| Exhibit | | |
| Number | | Description |
| | | |
| 5.1 | | Opinion of James J. Bergin, Assistant General Counsel of the Company. |
| | | |
| 23.1 | | Consent of James J. Bergin, Assistant General Counsel of the Company (included in Exhibit 5.1 of this current report). |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, Johnson & Johnson has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | JOHNSON & JOHNSON
| |
| | By: | /s/ Steven M. Rosenberg | |
| | | Steven M. Rosenberg | |
| | | Secretary | |
| |
| Date: June 23, 2008 | | | |
3
EXHIBIT INDEX
| | | |
| Exhibit | | |
| Number | | Description |
| | | |
| 5.1 | | Opinion of James J. Bergin, Assistant General Counsel of the Company. |
| | | |
| 23.1 | | Consent of James J. Bergin, Assistant General Counsel of the Company (included in Exhibit 5.1 of this current report). |
4
